Amazon affiliate link
Alcohol pads
MED PRIDE, 70% isopropyl, 200 count per listing. An alcohol pad does not establish sterility of a research product.
View on Amazon ↗Research blends
CJC-1295 (No DAC) / Ipamorelin Blend
research guide
This product combines two separate research peptides, CJC-1295 without DAC (Modified GRF 1-29) and ipamorelin, in a single vial at a stated combined milligram amount. No clinical or preclinical study of this specific combined formulation was located in the Europe PMC search conducted for this page. Evidence discussed here comes from studies of the individual component peptides studied separately, not from any trial of the blended product itself, and should not be read as blend-specific evidence.
Component studies do not validate this commercial blend. Literature summary, not clinical peer review.
Looking for the product? Reign listings and business disclosure ↓
Jorge Abreu is not a doctor. This is an educational research summary, not a prescription or a personal dosing plan. Study results do not establish that a supplier product is safe or effective for people. Consult a licensed clinician about medical decisions.
01 · Start with identity
What is CJC-1295 (No DAC) / Ipamorelin Blend?
This is a supplier-formulated combination product, not a molecule studied in the literature. CJC-1295 No DAC and ipamorelin are each distinct peptides with their own pharmacology; combining them in one vial is a manufacturing and convenience decision by the supplier, not a tested pharmacological entity, and no ratio-specific research exists for this or any other blend ratio in the sources reviewed.
Also searched as: Mod GRF 1-29 + Ipamorelin combination vial
02 · Read the evidence
What the studies reported
01
Component evidence for ipamorelin, not the blend
A human pharmacokinetic-pharmacodynamic study of ipamorelin alone, administered intravenously to healthy male volunteers, found dose-proportional pharmacokinetics and measurable growth hormone responses; this describes ipamorelin in isolation, not the combined product. [1]
02
Component evidence for the DAC-conjugated relative, not this blend
Human trial data exists for CJC-1295 with DAC, a chemically different, affinity-complex-modified relative of the CJC-1295 No DAC used in this blend; that data describes a different molecule and does not establish evidence for either the no-DAC component or the combined product. [2]
03 · Numbers in context
What does dosing evidence actually support?
No dosing study of this combined formulation exists in the sources reviewed. Available human data covers ipamorelin alone, given intravenously in a small monitored cohort, and CJC-1295 with DAC, a chemically distinct relative of one component; neither describes a validated protocol for a combined subcutaneous research vial containing both peptides together.
A study dose is not a personal dose. Population, route, formulation and supervision are part of the result. Online community schedules are not treated here as established clinical protocols.
04 · Safety and limits
What not to overlook
- No trial data exists for this specific blend; findings on individual peptides do not establish safety or effect of the combination.
- CJC-1295 No DAC and ipamorelin have different chemical structures and half-lives from each other and from the DAC-conjugated CJC-1295 relative referenced in the sources.
- No FDA-approved indication exists for either component or the combined product.
- The stated combined milligram amount reflects the supplier's manufacturing specification, not a studied dose ratio.
05 · Product distinctions
Names are not interchangeable
Reign Peptide sells this as a single lyophilized powder vial containing both CJC-1295 (No DAC) and ipamorelin at a supplier-stated total milligram amount per vial; the relative ratio of the two peptides in the vial is not something this review independently verified, and no published research establishes an evidence-based ratio for combining them.
06 · Handling and storage
Follow validated product instructions
A single water volume, refrigerator temperature or expiry window cannot be assumed for every compound and formulation. Use the exact manufacturer documentation and a validated laboratory procedure. If stability, solvent compatibility or microbiological quality is not documented, those properties remain unverified.
Refrigeration, clear appearance and bacteriostatic water do not make an unverified research product suitable for injection. This guide does not provide a mixing or administration procedure.
The existing concentration calculator checks arithmetic only. It cannot choose a safe dose or establish compatibility, sterility or shelf life.
Reign Peptide · Business disclosure
Research product listings
Jorge Abreu is involved in Reign Peptide. Links to Reign are a business connection, not an independent endorsement. Reign lists these products for laboratory research, not human consumption.
Use the listing to check the labeled identity, amount and available batch documentation. A purity result alone does not verify sterility, clinical suitability or equivalence to a medicine used in a trial.
Names and sizes are product labels, not dosing recommendations. Confirm current details with the seller.
Supplies and accessories
Compare the actual specifications
Jorge's supply directory includes syringes, alcohol pads, storage cases, travel refrigeration and electrolytes, with separate links for the two travel refrigeration options. Accessory availability is not a recommendation to administer a research compound.
Affiliate disclosure: As an Amazon Associate I earn from qualifying purchases.
Amazon affiliate link
Peptide fridge case
Listing: 63 slots for 3mL bottles, bag only. An organizer is not active refrigeration or a validated storage system.
View on Amazon ↗Amazon affiliate link
Peptide travel case
Medineed travel case with temperature display and two ice packs per listing. Check dimensions and transport requirements.
View on Amazon ↗Questions still worth asking
What remains unresolved?
- Has any controlled study evaluated whether combining a GHRH analog and a growth hormone secretagogue produces different pharmacodynamics than either alone?
- What per-component purity and ratio verification, if any, is available for supplier-blended vials like this one?
Check the source
References and evidence scope
- Human trial · 1999Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers ↗
- Human trial · 2006Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults ↗
These are the sources reviewed for this page, not an exhaustive systematic review. Related compound research is identified as such. Product links are not scientific references.
Keep reading